Investment case
Elevance Health, Inc.
ELV · 2 developments mapped · last assessed 2026-09-14
Market Ontology has mapped 2 macro, policy, and market developments to Elevance Health, Inc. since 2026-09-05. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for ELV yet, so no modelled value is shown. The ELV valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run ELV on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Strongest support
UnitedHealth Medical Care Ratio Drops to 85.3% as 2026 EPS Consensus Rises 21%
Second-order effect: As a major competitor, ELV may also benefit from broader favorable medical cost trends, potentially leading to improved profitability or reduced pressure on their medical care ratio.
· Moves profitability margins, industry growth outlook
- Open question
Centene Restructures Medicare Advantage Footprint to Target 2027 Margin Breakeven
Competitive dynamics within the Medicare Advantage market, particularly for dual-eligible members, and potential for sector-wide margin pressure/expectations.
· Moves market share stability in medicare advantage, pricing power in competitive ma segments, medical cost trends for dual eligible populations
What changed, by assumption
- 2026-09-05UnitedHealth Medical Care Ratio Drops to 85.3% as 2026 EPS Consensus Rises 21%
- 2026-09-14Centene Restructures Medicare Advantage Footprint to Target 2027 Margin Breakeven
Assumption changes
Full ledger →| Date | Assumption | Direction | Why | Conf. |
|---|---|---|---|---|
| 2026-07-15 | Margin | Bearish | The benefit expense ratio increased 80 basis points year over year, driven by expected elevated medical cost trend in Government businesses. | 0.90 |
| 2026-07-15 | Share count | Bearish | Company repurchased 0.7 million shares in Q2 2026 and has $5.3 billion remaining in authorization. | 0.90 |
| 2026-07-15 | Working capital | Bearish | Cash dividend reduces cash on hand. | 0.70 |
| 2026-07-15 | Share count | Bearish | Repurchase reduces shares outstanding. | 0.70 |
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-14 | Centene Restructures Medicare Advantage Footprint to Target 2027 Margin Breakeven | mixed | 3-12m | 0.40 |
| 2026-09-05 | UnitedHealth Medical Care Ratio Drops to 85.3% as 2026 EPS Consensus Rises 21% | Bullish | 1-3m | 0.60 |